Recently, TCL Technology Group Co., Ltd. ("TCL Technology", the "Group") announced the Group's first sustainability-linked syndicated loan, with a total amount of US$200 million. This is considered to ...

ACEN, in partnership with UPC Renewables, has commenced construction of two major renewable energy projects in India: a 420 MW solar farm in Rajasthan and a 120 MW wind farm in Karnataka. These new ...

As of early 2025, GE serves a cumulative total of over 8 million learners across Vietnam and in 34 countries. The company's achievement of profitability during a challenging investment climate ...

Imagine watching the match on a 100-inch ULED MiniLED U7 Series TV, where every kick, save, and celebration burst into life with breathtaking clarity. Designed for fans who want to feel like they're ...

BEIJING, June 24, 2025 /PRNewswire/ -- On June 19, the 3rd Wave Music Awards – Honor Ceremony concluded splendidly at the Beijing Performing Arts Center. Initiated by the Wave Music Committee and ...

Vantage Shines at Money Expo Colombia 2025 with Industry Recognition and Dynamic Engagement PORT VILA, Vanuatu, July 4, 2025 /PRNewswire/ -- Vantage Markets wrapped up a highly successful showing at ...

KUALA LUMPUR, Malaysia, June 10, 2025 /PRNewswire/ -- Building on its consistent excellence and deep commitment to the SME ecosystem, Hong Leong Bank ("HLB" or "the Bank") has been named the Best SME ...

HONG KONG, June 18, 2025 /PRNewswire/ -- The Battery Show Asia (TBSA), Asia's flagship exhibition for battery, energy storage and e-mobility technologies, will make its highly anticipated debut at ...

SHANGHAI, June 20, 2025 /PRNewswire/ -- HKRI Taikoo Hui HKRI Centres today officially unveiled TERRA, an innovative third space located on the 38 th floor of HKRI Centre One, one of the complex's two ...

Under the terms of the agreement, Otsuka is granted an exclusive license to develop, manufacture, and commercialize HBM7020, a BCMAxCD3 bispecific T-cell engager globally, excludi ...

Highlights Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64 Cu-SAR-Bombesin was safe, well tolerated and effective at detecting prostate cancer in patients with biochemical ...